Intelligence · Clinical pipeline
Phase III Pipeline Programs
Late-stage pivotal and registrational clinical programs nearing regulatory submission.
Quick answer
NovaPharmaNews tracks 5,427 phase iii pharmaceutical pipeline programs from ClinicalTrials.gov. Late-stage pivotal and registrational clinical programs nearing regulatory submission.
Top sponsors
- Takeda 393 programs
- United Therapeutics Europe 199 programs
- Anaxis Pharma 198 programs
- Chinese Academy of 189 programs
- Teva Pharma 148 programs
- Novartis India 145 programs
- BRIGHT MINDS BIOSCIENCES 139 programs
- PARItec 139 programs
- HOFFMANN-LA ROCHE 134 programs
- Regeneron UK 129 programs
- AstraZeneca 120 programs
- First People's Hospital 117 programs
Pipeline programs
-
HBS-301 tablet
Harmony Biosciences Holdings
Idiopathic Hypersomnia
1 trial -
HCB-ONC002
The George Institute
HER2-positive early breast cancer
1 trial -
HD201
Prestige Biopharma Belgium
HER2 Positive Breast Cancer
1 trial -
HEC585
Sunshine Guojian Pharmaceutical (Shanghai) Co.,
Idiopathic Pulmonary Fibrosis (IPF)
1 trial -
HEC74647PA+HEC110114
Sunshine Guojian Pharmaceutical (Shanghai) Co.,
Chronic HCV Infection
1 trial -
HEPARIN , NADROPARIN
Disc Medicine
All patients who receive ECMO treatment during the study period in one the participating centers from which (deferred) informed consent is obtained. Patients in whom the ECMO is only used to bridge a procedure like a high risk percutaneous coronary intervention or during surgery are excluded.
1 trial -
HIPEC with neoadjuvant chemotherapy
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Gastric Cancer
1 trial -
HLD200 methylphenidate hydrochloride capsules
COLLEGIUM PHARMACEUTICAL, INC
Attention Deficit Hyperactivity Disorder
1 trial -
HLX02
Shanghai Henlius Biotech
Breast Cancer
1 trial -
HM16/047
Takeda
Multiple Myeloma
1 trial -
HOVON 127 BL
Wuhan Createrna Science and Technology Co., Ltd
Burkitt lymphoma
1 trial -
HQP1351AG301
Lacuna Pharma Pty Ltd
Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Ph+ ALL)
1 trial -
HQP1351CG301
Lacuna Pharma Pty Ltd
Chronic Phase Chronic Myeloid Leukemia
1 trial -
HS-19-647
Camurus Pty Ltd
Acromegaly
1 trial -
HS-19-657
Camurus Pty Ltd
gastroenteropancreatic neuroendocrine tumors
1 trial -
HS-20094 Injection
Jian Li
Type 2 Diabetes
1 trial -
HSK3486-309
Lacuna Pharma Pty Ltd
General anaesthesia
1 trial -
HVA
The First People's Hospital of Lianyungang
Newly Diagnosed Acute Myeloid Leukemia With High Risk
1 trial -
HX-H2112345
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Radiation Proctitis
1 trial -
HYP-NOR
COLLEGIUM PHARMACEUTICAL, INC
hypotension in non-cardiac surgery
1 trial -
HYQVIA
Takeda
Chronic Inflammatory Demyelinating Polyradiculoneuropathy
2 trials -
HZNP-DAZ-301
Elan Pharma International
Sjögren’s Syndrome With Moderate-to-severe Systemic Disease Activity
1 trial -
HZNP-DAZ-303
Elan Pharma International
Sjögren’s Syndrome With Moderate-toSevere Symptom State
1 trial -
Hard capsules, BIIB141
Biogen
Friedreich’s ataxia
1 trial -
HealthWise South Africa curriculum
BRIGHT MINDS BIOSCIENCES INC.
Substance-Related Disorders
1 trial -
Hepatitis B adjuvanted vaccine
GlaxoSmithKline
Hepatitis B
1 trial -
Herceptin
Hoffmann-La Roche
Breast Neoplasms
1 trial -
Hexaxim®
Sanofi Pasteur
Diphtheria
1 trial -
High Dose Colchicine (4.8 mg total dose)
Takeda
Gout
1 trial -
Home non-invasive ventilation
United Therapeutics Europe Ltd
Hypercapnic Respiratory Failure
1 trial -
Hormonal Contraception
United Therapeutics Europe Ltd
Pregnancy
1 trial -
Hormone replacement therapy (estrogen/progestin)
United Therapeutics Europe Ltd
Anorexia Nervosa
1 trial -
Household-based water treatment with NADCC tablets
United Therapeutics Europe Ltd
Diarrhoea
1 trial -
Houyanqing Oral Liquid
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Nasopharyngeal Cancinoma (NPC)
1 trial -
Human Erythropoiesis Injection (CHO cell)
Sunshine Guojian Pharmaceutical (Shanghai) Co.,
Kidney Failure, Chronic
1 trial -
Human Insulin Inhalation Powder
Eli Lilly and Company
Diabetes Mellitus
1 trial -
Human Norovirus Bivalent (GⅠ.1/GⅡ.4)Vaccine,Recombinant (Hansenula polymorpha)
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Norovirus Infections
1 trial -
Human rotavirus liquid vaccine
GlaxoSmithKline
Infections, Rotavirus
1 trial -
Hyalobarrier
Green Valley (Shanghai) Pharmaceuticals Co.,
Thyroid Disease
1 trial -
Hydrocodone ER
Teva Pharma GmbH
Chronic Pain
2 trials -
Hydrocodone ER
Teva Pharma GmbH
Low Back Pain
2 trials -
Hydrocortisone
NEUROCRINE BIOSCIENCES INC
Congenital Adrenal Hyperplasia
2 trials -
Hylenex
HALOZYME THERAPEUTICS, INC.
Pain
1 trial -
Hyperthermic Intraperitoneal Chemotherapy (HIPEC)
The First People's Hospital of Lianyungang
Gastric Cancer
1 trial -
Hypnotic Medication Open-Label Taper
BRIGHT MINDS BIOSCIENCES INC.
Hypnotic Dependence Among Those With Insomnia
1 trial -
I004
Amphastar France Pharmaceuticals
Pharmacokinetics
2 trials -
I3Y-MC-JPCF
Eli Lilly Co.
Breast Cancer
1 trial -
I3Y-MC-JPCM
Eli Lilly Co.
Prostate Cancer
1 trial
Frequently asked questions
How many Phase III pipeline programs are in the directory?
5,427 published programs match this development stage in our ClinicalTrials.gov index.
What defines this pipeline stage?
Phase and status reflect ClinicalTrials.gov registry fields at last sync. See our clinical trial phases reference for methodology.